Evidence map›Paper›PMID 40626846›Full record

ArticleThe Laryngoscope2025

The Longitudinal Impact of Radiotherapy on Osseointegrated Hearing Aid Outcomes and Complications.

Benjamin D Lovin, Mike Hernandez, Paul W Gidley, Karine Al Feghali, Jack Phan, Catherine Wang, Congjun Wang, Dianna Roberts, Marc-Elie Nader

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Laryngoscope, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Benjamin D LovinBobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-8923-6527
Mike HernandezDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Paul W GidleyDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0003-3706-8781
Karine Al FeghaliDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jack PhanDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Catherine WangDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Congjun WangDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Dianna RobertsDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Marc-Elie NaderDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0001-9295-0174

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

objectiveTo evaluate the impact of radiotherapy on osseointegrated hearing aids (OIHA) complications.

methodsRetrospective review of percutaneous OIHA performed from 2006 to 2021 at an academic institution. Implant and abutment-related complications were evaluated and stratified by radiation parameters. Main outcome measures were abutment, implant, and major complications assessed using the modified Holgers and IPS grading scales.

resultsTotal of 190 OIHA were included; 124 (65%) were placed in bones that previously or subsequently received radiation. Total of 84 (44%) OIHA experienced at least one complication at mean 43.3 months. Radiation cohort had greater rates of having any complication (p = 0.032), major complication (p = 0.014), implant complication (p = 0.007), and abutment complication (p = 0.032). IPS score distribution was significantly different between groups (p = 0.011). Subgroup analysis of periauricular skin and parotid tumors demonstrated a significant association between any complication and abutment size (p = 0.005) and length of follow-up (p < 0.001) on logistic regression. Notably, every 1 mm increase in abutment size decreased the risk of any complication by 23%, and every 1-year increase in follow-up increased the risk of any complication by 67%. There was a trend toward more implant and abutment complications with higher radiation doses. Cumulative incidence plots demonstrate a greater discrepancy in complication rates between groups as time increases.

conclusionRadiation significantly increases the risk of both abutment and implant-related OIHA complications, particularly in the long term. Ongoing surveillance for complications in this population is critical. The IPS grading scale may be more sensitive for cataloging complications. Increasing the abutment size and decreasing radiation dosages may decrease complications. LEVEL OF EVIDENCE: 3:

Indexed as

Hearing AidsOsseointegrationPostoperative ComplicationsRadiotherapyAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomecomplicationsHolgers grading scaleIPS scaleosseointegrated hearing aidsradiation

Identifiers

PMID40626846
PMCPMC12706542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.